Results: Overall, 6,633 patients were included, with Asian region contributing more than half of cases, LATAM sites with 496 patients (Table)
At doses approved for weight loss, Saxenda is about 50% as effective as Wegovy (semaglutide 2.4 mg SC weekly)
These include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea (common, affecting up to 1 in 10 people) Vomiting (common) Constipation (common) Abdominal pain and discomfort (common) These gastrointestinal effects create the conditions for dehydration , which subsequently causes urine to become concentrated and darker
This comprehensive approach aims to elucidate the potential association between complement dysregulation and the severity of MASLD
Ulcerative colitis
p 99.5 cm2/m2).The cumulative risk curve showed that the mortality risk of patients in the low SATI group and the high SATI group was higher than that in the standard SATI group, and there was no significant difference in the cumulative mortality rate between the patients in the low SATI (P=0.292) and high SATI groups (P=0.198) compared with the standard SATI group